| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000012939 |
| Receipt No. | R000015006 |
| Official scientific title of the study | A clinical trial of the effect of chocolate containing the plant extract on improving blood glucose level |
| Date of disclosure of the study information | 2014/07/31 |
| Last modified on | 2019/01/28 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | A clinical trial of the effect of chocolate containing the plant extract on improving blood glucose level | |
| Title of the study (Brief title) | A clinical trial of the effect of chocolate containing the plant extract on improving blood glucose level | |
| Region |
|
|
| Condition | ||
| Condition | diabetes | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effect on improving fasting blood glucose level by the administlation of chocolate containing the plant extract for 8 weeks |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Blood glucose, HbA1c and insulin level at each visit (-4W, 0W, 4W, 8W)
|
| Key secondary outcomes | Blood triglyceride level, BMI and body component analysis at each visit (-4W, 0W, 4W, 8W) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 20.4 g/day for 8 weeks as a replacement for snack between meals
|
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Fasting blood glucose level more than(>=)100 mg/dL
2) HbA1c(NGSP)level between(>=) 5.6% to (<)6.9% 3) Fasting serum triglyceride level (>=)100 mg/dL 4) BMI level more than(>=) 25 kg/square meter 5) Nonsmoker 6) Subject, upon briefing of the content of the present study, fully understands and agrees to its objective and is able to personally give written informed consent |
|||
| Key exclusion criteria | 1) Subject taking any diabetes treatment(pharmacotherapy, diet therapy, exercise therapy etc)
2) Subject regularly taking any FOSHU or health food which is capable of improving blood glucose level 3) Subject having no habit of having a snack between meals 4) Subject who ended participation in another clinical trial less than 3 months before and who is currently involved in another clinical trial 5) For female subjects: pregnancy or possibility of pregnancy, or intending to become pregnant during this clinical trial 6) Subject who should have diabetes treatment by the investigator's judgement 7) Subject having a possibility to cause allergy symptoms(especially allergy to soybean) related to clinical test 8) Subject determined unsuitable by the investigator |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Kajimoto Osami |
| Organization | Osaka City University Graduate School of Medicine |
| Division name | Department of Medical Science on Fatigue |
| Address | 1-4-3 Asahimachi, Abeno-ku, Osaka |
| TEL | 06-6645-6171 |
| kajimoto@med.osaka-cu.ac.jp | |
| Public contact | |
| Name of contact person | Sugino Tomohiro |
| Organization | Soiken Inc. |
| Division name | R&D Division |
| Address | Senri Life Science Center 13F,1-4-2,Shinsenri-higashimachi, Toyonaka, Osaka |
| TEL | 06-6871-8888 |
| Homepage URL | |
| sugino@soiken.com | |
| Sponsor | |
| Institute | Soiken Inc. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Sunstar Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015006 |